All In Biotech

Drug Trial Radar · NCT03191526

A Study of KW-0761 in Subjects With HTLV-1 Associated Myelopathy (HAM)

A Phase 3 Multicenter, Randomized, Double-Blind and Placebo-Controlled Study, and Open Study of KW-0761 in Patients With HTLV-1 Associated Myelopathy (HAM)

Last checked: Nov 20, 2026Latest source record: Apr 14, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

66

Actual

Start

May 22, 2017

Primary completion

Jun 6, 2019

Study completion Aug 31, 2021

Sponsor

Lead sponsor
Kyowa Kirin Co., Ltd.Industry
Sponsor type
Industry
First posted
Jun 19, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 20 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to assess the efficacy and safety of KW-0761 after intravenous injections in subjects with HTLV-1 associated myelopathy (HAM) in Japan.

Conditions

  • HTLV-1 Associated Myelopathy

Interventions

  • KW-0761 0.3 mg/kg IVDrug

    Intravenous injection every 12 weeks.

  • Placebo (saline)Drug

    Intravenous injection every 12 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Improvement in Osame's motor disability scoreTime frame: At week 4, 8 and 12 after second injection

Locations

16 sites in 1 country. Site status is shown where the registry gives one.

  • University Hosipital, Kyoto Prefectural University of Medicine

    Kyoto, Japan

  • Nagoya University Hosipital

    Nagoya, Aichi-ken, Japan

  • Ehime University Hospital

    Tone, Ehime, Japan

  • Fukuoka University Hospital

    Fukuoka, Fukuoka, Japan

  • Kyushu University Hospital

    Fukuoka, Fukuoka, Japan

  • Hospital of the University of Occupational and Environmental Health, Japan

    Kitakyushu, Fukuoka, Japan

  • Kagoshima City Hospital

    Kagoshima, Kagoshima-ken, Japan

  • Kagoshima University Hospital

    Kagoshima, Kagoshima-ken, Japan

  • St. Marianna University School of Medicine Hospital

    Kawasaki, Kanagawa, Japan

  • Kumamoto University Hospital

    Kumamoto, Kumamoto, Japan

  • Tohoku University Hosipital

    Sendai, Miyagi, Japan

  • Fujimoto General Hospital

    Miyakonojō, Miyazaki, Japan

  • Oita Prefectural Hospital

    Ōita, Oita Prefecture, Japan

  • National Hospital Organization Okinawa National Hospital

    Ginowan, Okinawa, Japan

  • University of the Ryukyus Hospital

    Nakagami, Okinawa, Japan

  • Kansai Medical University Hosipital

    Hirakata, Osaka, Japan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.